Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT02844816What this trial is testingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerWho this might be right forRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more National Cancer Institute (NCI) 172
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Early research (Phase 1)WithdrawnNCT04972253What this trial is testingPhase I BLASST-3 TrialWho this might be right forBladder Transitional Cell CarcinomaBladder CancerFibroblast Growth Factor Receptor Guru P. Sonpavde
Large-scale testing (Phase 3)Study completedNCT00004154What this trial is testingFenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Cancer M.D. Anderson Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT00445601What this trial is testingS0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer SWOG Cancer Research Network 406
Early research (Phase 1)Study completedNCT03258593What this trial is testingDurvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)Who this might be right forUrinary Bladder Neoplasms National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00238420What this trial is testingPaclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Urothelial CarcinomaStage I Bladder Cancer AJCC v6 and v7Stage II Bladder Cancer AJCC v6 and v7+1 more National Cancer Institute (NCI) 70
Post-approval studies (Phase 4)Study completedNCT02910596What this trial is testingEffectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIAWho this might be right forBladder Dysfunction Department of Medical Services Ministry of Public Health of Thailand 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068What this trial is testingStudy of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesWho this might be right forOvarian CancerBreast CancerPancreatic Cancer+10 more AstraZeneca 702
Large-scale testing (Phase 3)UnknownNCT00553345What this trial is testingSelenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer University of Birmingham 515
Early research (Phase 1)Study completedNCT02311101What this trial is testingPhase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder CancerWho this might be right forUrinary Bladder Neoplasm The University of Texas Health Science Center at San Antonio 18
Testing effectiveness (Phase 2)Study completedNCT04892342What this trial is testingStudy of ESG401 in Adults With Solid TumorsWho this might be right forNeoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more Shanghai Escugen Biotechnology Co., Ltd 156
Early research (Phase 1)Study completedNCT01517464What this trial is testingA Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid TumorsWho this might be right forNeoplasm SynerGene Therapeutics, Inc. 13
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Early research (Phase 1)Study completedNCT00782587What this trial is testingStudy of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder CancerWho this might be right forSuperficial Bladder Cancer Halozyme Therapeutics 14
Early research (Phase 1)Study completedNCT00544609What this trial is testingSorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative IntentWho this might be right forBladder Cancer Spanish Oncology Genito-Urinary Group 10
Testing effectiveness (Phase 2)Looking for participantsNCT05944237What this trial is testingHTL0039732 in Participants With Advanced Solid TumoursWho this might be right forNeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more Cancer Research UK 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT02202772What this trial is testingIntravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the BladderWho this might be right forUrothelial Carcinoma of the Urinary Bladder Guarionex J. Decastro 51
Early research (Phase 1)Study completedNCT02619253What this trial is testingPhase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell CarcinomaWho this might be right forRenal Cell CarcinomaUrinary Bladder Neoplasms Nabil Adra 52